Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Masui ; 60(2): 224-6, 2011 Feb.
Artigo em Japonês | MEDLINE | ID: mdl-21384663

RESUMO

Idiopathic anaphylaxis is a rare disease that induces anaphylactic shock without extrinsic incentive. We had a patient with such frequent episodes undergoing laparoscopic cholecystectomy. Steroid was administered both at preoperative and intraoperative periods. Epidural anesthesia and general anesthesia by inhalation anesthesia, which are low risk for anaphylaxis, were used to reduce perioperative stress and restricted usage of drugs even in postoperative period. Consequently, we can safety manage anesthesia without episode of anaphylactic shock. To prepare for anaphylaxis we prepared usual therapeutic drugs for shock and measured serum tryptase, which has longer half-life than that of histamine.


Assuntos
Anafilaxia/prevenção & controle , Anestesia Epidural , Anestesia Geral , Colecistectomia Laparoscópica , Anafilaxia/diagnóstico , Biomarcadores/sangue , Humanos , Masculino , Pessoa de Meia-Idade , Assistência Perioperatória , Prevenção Secundária , Triptases/sangue
2.
Anesth Analg ; 108(3): 987-91, 2009 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-19224814

RESUMO

BACKGROUND: A topical lidocaine patch is effective in the treatment of posttraumatic peripheral neuropathy (PTPN), but it is not suited for breakthrough pain because of difficulty with an additional application. Here, we examined the effect of 8% lidocaine pump spray (Xylocaine pump spray, XPS) on peripheral neuropathic pain caused by surgery or injury. METHODS: Thirty-one patients with PTPN were randomized to receive either XPS or saline placebo pump spray applied to painful skin areas. The optimal dose of up to 30 sprays (0.1 mL/single spray, 30 times) was individually determined as the dose which completely covered the painful site. After a 7-day period, the patients were crossed over to receive the optimal dose of the alternative spray. Pain was assessed with a visual analog scale. RESULTS: XPS, but not placebo pump spray, significantly decreased the visual analog scale for continuing pain and tactile allodynia. The effect persisted for a median of 5 h (range, 2-60 h) after application. Mild side effects were reported in three patients with XPS consisting of local irritation (n = 3) and local flare (n = 1). All adverse events disappeared without medication within a few hours. CONCLUSIONS: The present study suggests that XPS provides a significant improvement in PTPN due to its prompt analgesia, lack of systemic side effects and convenience.


Assuntos
Anestésicos Locais/administração & dosagem , Anestésicos Locais/uso terapêutico , Lidocaína/administração & dosagem , Lidocaína/uso terapêutico , Dor/tratamento farmacológico , Dor/etiologia , Doenças do Sistema Nervoso Periférico/tratamento farmacológico , Doenças do Sistema Nervoso Periférico/etiologia , Ferimentos e Lesões/complicações , Adulto , Idoso , Idoso de 80 Anos ou mais , Anestésicos Locais/efeitos adversos , Método Duplo-Cego , Feminino , Humanos , Lidocaína/efeitos adversos , Masculino , Inaladores Dosimetrados , Pessoa de Meia-Idade , Medição da Dor , Projetos Piloto , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA